Background: The phenomenon ‘autodestructive behaviour’ is becoming an increasingly serious disease and cost factor in a wide range of medical fields. The present paper presents a survey of the literature on autodestructive behaviour, excluding psychotic, substance-induced or organic brain disorders. Starting out with a conceptual overview, the paper goes on to look into the epidemiology of autodestructive behaviour and the forms in which it manifests itself. Method: A literature search was conducted in Medline, Psycinfo and Psyndex using the search terms ‘artifact’, ‘artificially induced’, ‘autodestructive’, ‘self-mutilation’, ‘factitious’, ‘self-harm’, ‘self-induced’, ‘self-inflicted’, ‘self-injuring’ and ‘self-mutilation’ for the period from 1977 to 2003. Results: Five of a total of 18 empirical studies describe the simultaneous occurrence of direct and indirect forms of autodestructive behaviour. Reported prevalence rates range from 0.032% to 9.36%. The ratio of females to males was found to be 2:1 (average age: 31.5 years; SD: 9.3 years); in contrast, the gender ratio was reversed for Munchausen’s syndrome. The case history data presented are patchy and differ in terms of their priorities. We found a large number of codiagnoses, which seems to indicate that personality and dependence disorders, or substance misuse, are characteristic of both direct and indirect forms of autodestructive behaviour. Conclusions: The task at hand is to use a yet-to-be-developed nomenclature and adequately operational diagnostic criteria to work out standardised survey instruments that do justice to the heterogeneity of this disorder complex.

1.
Eisendrath SJ, Feder A: Management of factitious disorders; in Feldman MD, Eisendrath SJ (eds): The Spectrum of Factitious Disorders. Washington, American Psychiatric Press, 1996, pp 195–213.
2.
Eckhardt-Henn A: Artifizielle Störungen und Münchhausen-Syndrom: Gegenwärtiger Stand der Forschung. Psychother Psychosom Med Psychol 1999;49:75–89.
3.
Freyberger HJ, Jantschek G, Schneider W: Die Klassifikation artifizieller Störungen in der ICD-10: Ergebnisse der Forschungskriterienstudie; in Schneider W, Freyberger HJ, Muhs A, Schüssler G (eds): Diagnostik und Klassifikation nach ICD-10. Göttingen, Vandenhoeck & Ruprecht, 1993, pp 210–224.
4.
Sachsse U: Selbstverletzendes Verhalten. Psychodynamik – Psychotherapie. Göttingen, Vandenhoeck & Ruprecht, 1999.
5.
Plassmann R: Münchhausen syndromes and factitious diseases. Psychother Psychosom 1994;62:7–26.
6.
Freyberger H, Nordmeyer JP, Freyberger HJ, Nordmeyer J: Patients suffering from factitious disorders in the clinico-psychosomatic consultation liaison service: Psychodynamic processes, psychotherapeutic initial care and clinicointerdisciplinary cooperation. Psychother Psychosom 1994;62:108–122.
7.
Eckhardt A: Factitious disorders in the field of neurology and psychiatry. Psychother Psychosom 1994;62:56–62.
8.
Gieler U: Factitious disease in the field of dermatology. Psychother Psychosom 1994;62:48–55.
9.
Paar GH: Factitious disorders in the field of surgery. Psychother Psychosom 1994;62:41–47.
10.
Winchel RM, Stanley M: Self-injurious behavior: A review of the behavior and biology of self-mutilation. Am J Psychiatry 1991;148:306–317.
11.
Teegen F, Wiem S: Self-injurious behavior as a dysfunctional coping strategy. Z Klin Psychol Psychiatr Psychother 1999;47:386–398.
12.
Suyemoto KL: The functions of self-mutilation. Clin Psychol Rev 1998;18:531–554.
13.
Simeon D, Hollander E: Self-Injurious Behaviors – Assessment and Treatment. Washington, American Psychiatric Publishing, 2001.
14.
Stirn A: Body piercing: Medical consequences and psychological motivations. Lancet 2003;361:1205–1215.
15.
Cadotsch A, Eichmann A: Die kutane Artefaktkrankheit – eine İbersicht mit Fallbeispielen. Schweiz Rundsch Med Prax 1984;73:1235–1241.
16.
Fliege H: Pathological self-destructive behaviour and behaviour therapy: A review. Psychotherapeut 2002;47:193–203.
17.
Eckhardt A: Offene und heimliche Selbstbeschädigung; in Egle U, Hoffmann S, Joraschky P (eds): Sexueller Missbrauch, Misshandlung, Vernachlässigung. Stuttgart, Schattauer, 1997, pp 259–270.
18.
Evans J, Platts H, Liebenau A: Impulsiveness and deliberate self-harm: A comparison of ‘first-timers’ and ‘repeaters’. Acta Psychiatr Scand 1996;93:378–380.
19.
Hung C-I, Liu C-Y, Liao M-N, Chang Y-H, Yang Y-Y, Yeh E-K: Self-destructive acts occurring during medical general hospitalization. Gen Hosp Psychiatry 2000;22:115–121.
20.
Feldman MD, Hamilton JC, Deemer HA: Factitious disorder; in Philipps KA (ed): Somatoform and Factitious Disorders. Review of Psychiatry. Washington, American Psychiatric Press, 2001, vol 20, pp 129–159.
21.
Dilling H, Mombour W, Schmidt MH: Internationale Klassifikation psychischer Störungen: ICD-10 Kapitel V (F): Klinisch-diagnostische Leitlinien. Bern, Huber, 1993.
22.
Wittchen HU, Sass H, Zaudig M, Koehler K: DSM-IV TR American Psychiatric Association: Diagnostisches und statistisches Manual psychischer Störungen. Weinheim, Beltz, 2003.
23.
Kinsella P: Factitious disorder: A cognitive behavioural perspective. Behav Cogn Psychother 2001;29:195–202.
24.
Solyom C, Solyom L: A treatment program for functional paraplegia/Munchausen’s syndrome. J Behav Ther Exp Psychiatry 1990;21:225–230.
25.
Paar GH: Offene und heimliche Selbstbeschädigung: Diagnostik, Klinik und Therapie; in Weglein E, Hellwig A, Schoof M (eds): Selbstvernichtung. Göttingen, Vandenhoeck & Ruprecht, 1996, pp 137–185.
26.
Herpertz S, Sass H: Offene Selbstschädigung. Nervenarzt 1994;65:296–306.
27.
Simeon D, Stanley M, Frances AJ, Mann JJ, Winchel R, Stanley M: Self-mutilation in personality disorders: Psychological and biological correlates. Am J Psychiatry 1992;149:221–226.
28.
Hirsch M: Syndromes related to factitious diseases. Psychother Psychosom 1994;62:63–68.
29.
Klapp BF, Danzer G: Aggression und Autoaggression als Krankheitsfaktoren; in Studt HH (ed): Aggression als Konfliktlösung? Prophylaxe und Psychotherapie. Heidelberg, Barth, 1996, pp 20–50.
30.
Willenberg H, Eckhardt A, Freyberger H, Sachsse U, Gast U: Self-destructive behavior: Classification and basic documentation. Psychotherapeut 1997;42:211–217.
31.
Herpertz S, Gretzer A, Steinmeyer EM, Sass H: Experimenteller Nachweis mangelnder Affektregulation bei Patientinnen mit selbstschädigendem Verhalten. Nervenarzt 1998;69:410–418.
32.
Herpertz S: Self-injurious behaviour. Acta Psychiatr Scand 1995;91:57–68.
33.
Kapfhammer HP, Rothenhäusler HB, Dietrich E, Dobmeier P, Mayer C: Artifizielle Störungen – Zwischen Täuschung und Selbstschädigung: Konsiliarpsychiatrische Erfahrungen an einem Universitätsklinikum. Nervenarzt 1998;69:401–409.
34.
Fliege H, Scholler G, Rose M, Willenberg H, Klapp BF: Factitious disorders and pathological self-harm in a hospital population: An interdisciplinary challenge. Gen Hosp Psychiatry 2002;24:164–171.
35.
Jantschek G, Rodewig K, Wietersheim JV, Muhs A: Concepts of Psychosomatic Disorders in ICD-10: Results of the Research Criteria Study. Psychother Psychosom 1995;63:112–123.
36.
Dilling H, Mombour W, Schmidt MH, Schulte-Markwort E: Internationale Klassifikation psychischer Störungen. ICD-10 Kapitel V (F): Forschungskriterien. Bern, Huber, 1994.
37.
Feldman MD, Eisendrath SJ, Stuart J: The Spectrum of Factitious Disorders. Clinical Practice No 40. Washington, American Psychiatric Press, 1996.
38.
Sachsse U: Overt self-injury. Psychother Psychosom 1994;62:82–90.
39.
Schuepbach MWM, Adler RH, Sabbioni MEE: Accuracy of the clinical diagnosis of ‘psychogenic disorders’ in the presence of physical symptoms suggesting a general medical condition: A 5-year follow-up in 162 patients. Psychother Psychosom 2002;71:11–17.
40.
Nadelson T: False patients/real patients: A spectrum of disease presentation. Psychother Psychosom 1986;44:175–184.
41.
Feldman MD: A critical analysis of factitious disorders; in Philipps KA (ed): Somatoform and Factitious Disorders. Washington, American Psychiatric Press, 2001, pp 129–159.
42.
Grabe HJ, Meyer C, Hapke U, Rumpf HJ, Freyberger HJ, Dilling H, John U: Somatoform pain disorder in the general population. Psychother Psychosom 2003;72:88–94.
43.
Herpertz S, Sass H, Favazza A: Impulsivity in self-mutilative behavior: Psychometric and biological findings. J Psychiatr Res 1997;31:451–465.
44.
Kringlen E: Obsessional neurotics: A long-term follow-up. Br J Psychiatry 1965;111:709–722.
45.
Lewis AJ. Obsessional disorder; in Scott R (ed): Price’s Textbook of the Practice of Medicine. London, Oxford Press, 1966.
46.
Kapfhammer HP, Dobmeier P, Mayer C, Rothenhäusler HB: Konversionssyndrome in der Neurologie. Psychother Psychosom Med Psychol 1998;48:463–474.
47.
Favazza AR, Conterio K: The plight of chronic self-mutilators. Community Ment Health J 1988;24:22–30.
48.
Klonoff EA, Youngner SJ, Moore DJ, Hershey LA: Chronic factitious illness: A behavioral approach. Int J Psychiatry Med 1983;13:173–183.
49.
Scarry E: Der Körper im Schmerz. Die Chiffren der Verletzlichkeit und die Empfindung der Kultur. Frankfurt, Fischer, 1992.
50.
Justus PG, Krutziger SS, Kitchens CS: Probing the dynamics of Munchausen’s syndrome. Ann Med 1980;93:120–127.
51.
Hirsch M: Der eigene Körper als Objekt. Zur Psychodynamik selbstdestruktiven Körperagierens. Berlin, Springer, 1989.
52.
Danzer G: Vom Sinn und Unsinn offener Selbstbeschädigung; in Lévy A (ed): Haut und Seele – ein Lehrbuch der Dermatologischen Psychosomatik. Würzburg, Königshausen & Neumann, 1997, pp 119–134.
53.
Ehlers W, Plassmann R: Diagnosis of narcissistic self-esteem regulation in patients with factitious illness (Munchausen’s syndrome). Psychother Psychosom 1994;62:69–77.
54.
Sachsse U: Selbstbeschädigung als Selbstfürsorge: Zur intrapersonalen und interpersonellen Psychodynamik schwerer Selbstbeschädigungen der Haut. Forum Psychoanal 1987;3:51–70.
55.
Linehan MM: Dialektisch-Behaviorale Therapie der Borderline-Persönlichkeitsstörung. München, CIP-Medien, 1996.
56.
Danzer G, Klapp BF: Zur Anthropologie und Tiefenpsychologie der Aggression: Modelle und Konzepte; in Studt HH (ed): Aggression und Autoaggression. Leipzig-Heidelberg, Barth, 1996, pp 9–19.
57.
Eckhardt A: Im Krieg mit dem Körper – Autoaggression als Krankheit. Reinbek, Rowohlt, 1994.
58.
Teegen F, Wiem S: Selbstverletzendes Verhalten als dysfunktionale Bewältigungsstrategie – Eine Befragung Betroffener im Internet. Z Klin Psychol Psychiatr Psychother 1999;47:386–398.
59.
Sonne S, Rubey R, Brady K, Malcolm R, Morris T: Naltrexone treatment of self-injurious thoughts and behaviors. J Nerv Ment Dis 1996;184:192–195.
60.
Hamann R: Selbstverletzendes Verhalten bei Frauen. Eine qualitative Studie. Berlin, Freie Universität Berlin, 1998.
61.
Freyberger H, Stieglitz RD: Artifizielle Störungen; in Berger M (ed): Psychiatrie und Psychotherapie. München, Urban & Fischer, 2000, pp 881–888.
62.
Sansone RA, Wiederman MW: The Self-Harm Inventory (SHI): Development of a scale for identifying self-destructive behaviors and borderline personality disorder. J Clin Psychol 1998;54:973–983.
63.
Keuthen NJ, Wilhelm S, Deckersbach T, Engelhard IM, Forker AE, Baer L, Jenike A: The skin picking scale – Scale construction and psychometric analyses. J Psychosom Res 2000;50:337–341.
64.
Gratz KL: Measurement of deliberate self-harm: Preliminary data on the deliberate self-harm inventory. J Psychopathol Behav Assess 2001;23:253–263.
65.
Gutierrez PM, Osman A, Barrios FX, Kopper BA: Development and initial validation of the self-harm behavior questionnaire. J Pers Assess 2001;77:475–490.
66.
Pope HG, Jonas JM, Jones B: Factitious psychosis: Phenomenology, family history, and long-term outcome of nine patients. Am J Psychiatry 1982;139:1480–1483.
67.
Fishbain DA, Goldberg M, Rosomoff HL: More Munchausen’s with chronic pain. Clin J Pain 1991;7:237–244.
68.
Aduan RP, Fauci AS, Dale DC, Herzberg JH, Wolff SM: Factitious fever and self-induced infection. Ann Intern Med 1979;90:230–242.
69.
Langbehn DR, Pfohl B: Clinical correlates of self-mutilation among psychiatric inpatients. Ann Clin Psychiatry 1993;5:45–51.
70.
Schmid C, Hochstrasser DH, Hell D: Selbstbeschädigung als Symptom psychischer Krankheiten in der PUK Zürich zwischen 1987 und 1995. Schweiz Arch Neurol Psychiatr 2000;151:184–189.
71.
Sutherland AJ, Rodin GM: Factitious disorders in a general hospital setting: Clinical features and a review of the literature. Psychosomatics 1990;31:392–399.
72.
Reich JD, Hanno PM: Factitious renal colic. Urology 1997;50:858–862.
73.
Spivak H, Rodin GM, Sutherland AJ: The psychology of factitious disorders: A reconsideration. Psychosomatics 1994;35:25–34.
74.
Eisendrath SJ: Factitious physical disorders: Treatment without confrontation. Psychosomatics 1989;30:383–387.
75.
Fras I, Coughlin BE: The treatment of factitial disease. Psychosomatics 1971;12:117–122.
76.
Kernberg OF: Schwere Persönlichkeitsstörungen. Stuttgart, Klett-Cotta, 1996.
77.
Roth AS, Ostroff RB, Hoffmann RE: Naltrexone as a treatment for repetitive self-injurious behaviour: An open-label trial. J Clin Psychiatry 1996;57:233–237.
78.
Mayr J: Die Artefakte der Haut; in Mayr J (ed): Handbuch der Artefakte. Jena, Fischer, 1937, pp 72–120.
79.
Rumans LW, Vosti KL: Factitious and fraudulent fever. Am J Med 1978;65:745–756.
80.
Bhugra D: Psychiatric Munchausen’s syndrome. Acta Psychiatr Scand 1988;77:497–503.
81.
Bauer M, Boegner F: Neurological syndromes in factitious disorder. J Nerv Ment Dis 1996;184:281–288.
82.
Friedl MC, Drajier N: Dissociative disorders in Dutch psychiatric inpatients. Am J Psychiatry 2000;157:1012–1013.
83.
Mohammed R, Goy JA, Walpole BG, Brentnall EW, Miller T: Munchausen’s syndrome. Med J Aust 2003;143:561–563.
84.
Knockaert DC, Vanneste LJ, Vanneste SB, Bobbaers HJ: Fever of unknown origin in the 1980s. An update of the diagnostic spectrum. Arch Intern Med 1992;152:55.
85.
Phillips RH, Alkan M: Some aspects of self-mutilation in the general population of a large psychiatric hospital. Psychiatr Q 1961;35:421–423.
86.
Papadopoulos MC, Bell BA: Factitious neurosurgical emergencies: Report of five cases. Br J Neurosurg 1999;13:591–593.
87.
Fliege H, Burkert U, Danzer G, Willenberg H, Klapp BF: Autodestruktives Verhalten – Vorkommen und Typologie in einer universitären psychosomatischen Einrichtung. Z Psychosom Med Psychother 2000;46:286–303.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.